Charles River Laboratories income from continuous operations for the twelve months ending September 30, 2024 was $0.428B, a 10.93% decline year-over-year.
Charles River Laboratories annual income from continuous operations for 2023 was $0.48B, a 2.48% decline from 2022.
Charles River Laboratories annual income from continuous operations for 2022 was $0.493B, a 23.51% increase from 2021.
Charles River Laboratories annual income from continuous operations for 2021 was $0.399B, a 9.18% increase from 2020.
Charles River Laboratories Income from Continuous Operations 2010-2024 | CRL